FASN and breast carcinoma: In breast cancer, a high demand of FA from de novo synthesis has been reported [63] as a response to the overexpression of several enzymes, such as fatty acid synthase (FASN) [23, 64], acetyl-CoA carboxylase (ACC) and ATP citrate lyase (ACLY) [65].